Supplemental Table 1 from Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma
Year: 2026
Type: supplementary-materials
Authors: Edward R. Scheffer Cliff, Guido D. Pelaez, Fei Wan, Varun Iyengar, Jihao Zhou, Kevin Chung, Nayef Abdel-Razeq, Jessica Allen, Ajay Major, John Sharp, Narendranath Epperla, Patrick Gould, Hua-Jay J. Cherng, Samin Houshyar, Danielle S. Wallace, Ryan C. Lynch, Avyakta Kallam, Matthew G. Mei, Reid W. Merryman, Michelle Fleyshman, Joanna M. Rhodes, Adam Kidwell, Timothy S. Fenske, Nikita Malakhov, Erin Mulvey, Marcus P. Watkins, Muhamad Alhaj Moustafa, Talal Hilal, Grzegorz S. Nowakowski, Yucai Wang, Pallawi Torka, David A. Russler-Germain
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7118743454
